Resources Contact Us Home
Oligoadenylate synthetase (OAS)

Image Number 2 for United States Patent #8133710.

The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.

  Recently Added Patents
Solar cell with hyperpolarizable absorber
Display screen or portion thereof with icon
Methods, systems and apparatus for displaying the multimedia information from wireless communication networks
Mixed reactant flow-by fuel cell
Electronic device assemblies
Information processing apparatus and storage medium for storing information processing program
  Randomly Featured Patents
Tool pack structure and contents execution device
Nasal hood with open-bottom mixing chamber
Sign holder
Device for treatment of erectile dysfunction
Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis
Handle assembly, top-load cartridge
Electric cooking and serving vessel
Non-destructive dissolved gas volume testing method
Secure system unit mobility
Package for flashlight